XML 46 R37.htm IDEA: XBRL DOCUMENT v3.22.1
STOCKHOLDERS' EQUITY, Restricted Stock and Stock Options (Details)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2022
USD ($)
Plan
$ / shares
shares
Mar. 31, 2021
USD ($)
shares
Dec. 31, 2021
USD ($)
$ / shares
shares
Jun. 16, 2020
shares
Stockholders' Equity Note Details [Abstract]        
Number of stock incentive plans | Plan 3      
Shares [Abstract]        
Outstanding, beginning balance (in shares) 81,000      
Granted (in shares) 0      
Vested (in shares) 0      
Canceled (in shares) (81,000)      
Outstanding, ending balance (in shares) 0   81,000  
Vested (in shares) 0      
Exercisable, ending balance (in shares) 0      
Weighted Average Exercise Price Per Share [Abstract]        
Outstanding, beginning balance (in dollars per share) | $ / shares $ 7.79      
Granted (in dollars per share) | $ / shares 0      
Vested (in dollars per share) | $ / shares 0      
Canceled (in dollars per share) | $ / shares 7.79      
Outstanding, ending balance (in dollars per share) | $ / shares 0   $ 7.79  
Vested or expected to vest (in dollars per share) | $ / shares 0      
Exercisable, ending balance (in dollars per share) | $ / shares $ 0      
Weighted Average Remaining Contractual Term [Abstract]        
Outstanding     2 months 1 day  
Aggregate Intrinsic Value [Abstract]        
Outstanding, beginning balance | $ $ 0      
Granted | $ 0      
Canceled | $ 0      
Vested | $ 0      
Outstanding, ending balance | $ 0   $ 0  
Vested or expected to vest | $ 0      
Exercisable, ending balance | $ $ 0      
Restricted Stock [Member]        
Shares [Abstract]        
Nonvested restricted stock outstanding, beginning balance (in shares) 1,743,846      
Granted (in shares) 528,121      
Canceled (in shares) 0      
Vested (in shares) (728,776)      
Nonvested restricted stock outstanding, ending balance (in shares) 1,543,191   1,743,846  
Weighted Average Grant Date Fair Value [Abstract]        
Nonvested restricted stock outstanding, beginning balance (in dollars per share) | $ / shares $ 3.89      
Granted (in dollars per share) | $ / shares 7.29      
Canceled (in dollars per share) | $ / shares 0      
Vested (in dollars per share) | $ / shares 3.91      
Nonvested restricted stock outstanding, ending balance (in dollars per share) | $ / shares $ 5.19   $ 3.89  
Recognized restricted stock expense | $ $ 1,200 $ 500    
Unrecognized restricted stock expense | $ 8,000   $ 4,400  
Stock Options [Member]        
Aggregate Intrinsic Value [Abstract]        
Unrecognized pre-tax compensation expense | $ $ 0      
2020 Plan [Member]        
Stockholders' Equity Note Details [Abstract]        
Number of shares available for issuance under incentive plan (in shares)       2,000,000
2020 Plan [Member] | June 16, 2020 [Member]        
Stockholders' Equity Note Details [Abstract]        
Stock option award issuance, plan duration 10 years      
LTIP [Member]        
Stockholders' Equity Note Details [Abstract]        
Number of shares available for issuance under incentive plan (in shares)       2,000,000
LTIP [Member] | Restricted Stock [Member]        
Weighted Average Grant Date Fair Value [Abstract]        
Outstanding restricted shares, intrinsic value | $ $ 11,000      
Non Employee Directors Plan [Member]        
Stockholders' Equity Note Details [Abstract]        
Net share settlement for restricted stock (in shares) 268,654 154,973    
Decrease in equity due to payment of tax for employee | $ $ 2,000      
Non Employee Directors Plan [Member] | Maximum [Member]        
Stockholders' Equity Note Details [Abstract]        
Decrease in equity due to payment of tax for employee | $   $ 1,000